GnRH agonist induces apoptosis in seminiferous tubules of immature rats: Direct gonadal action

Andrologia

Volumn 42, Issue 4, 2010, Pages 231-235

  Peirouvi, T ^a   Salami, S ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; buserelin; gonadotrophin releasing hormone; immature male rats; seminiferous tubules

Indexed keywords

BUSERELIN; DNA NUCLEOTIDYLEXOTRANSFERASE; EOSIN; GONADORELIN; HEMATOXYLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMATURITY; MALE; NICK END LABELING; NONHUMAN; RAT; SEMINIFEROUS TUBULE; TESTIS FUNCTION; AGONISTS; ANIMAL; DRUG EFFECTS; PATHOLOGY; SPERMATOCYTE; WISTAR RAT;

ANIMALS; APOPTOSIS; BUSERELIN; GONADOTROPIN-RELEASING HORMONE; IN SITU NICK-END LABELING; MALE; RATS; RATS, WISTAR; SEMINIFEROUS TUBULES; SPERMATOCYTES;

EID: 77954570523     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2009.00982.x     Document Type: Article

References (20)

1. Auclair C, Kelly PA, Coy DH, Schally AV, Labrie F (1977) Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat. Endocrinology 101: 1890 1893.
2. Billig H, Furuta I, Hsueh AJ (1994) Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology 134: 245 252.
3. Billig H, Furuta I, Rivier C, Tapanainen J, Parvinen M, Hsueh AJ (1995) Apoptosis in testis germ cells: developmental changes in gonadotropin dependence and localization to selective tubule stages. Endocrinology 136: 5 12.
4. Billig H, Chun SY, Eisenhauer K, Hsueh AJ (1996) Gonadal cell apoptosis: hormone-regulated cell demise. Hum Reprod Update 2: 103 117.
5. Botte MC, Chamagne AM, Carre MC, Counis R, Kottler ML (1998) Fetal expression of GnRH and GnRH receptor genes in rat testis and ovary. J Endocrinol 159: 179 189.
6. Cirkel U, Schweppe KW, Ochs H, Hanker JP, Schneider HP (1989) LH-RH agonist (buserelin): treatment of endometriosis. Clinical, laparoscopic, endocrine and metabolic evaluation. Arch Gynecol Obstet 246: 139 151.
7. Grundker C (2000) Cytotoxic luteinizing hormone-releasing hormone conjugates and their use in gynecological cancer therapy. Eur J Endocrinol 143: 569 572.
8. Huhtaniemi IT, Warren DW, Catt KJ (1985) Regulation of infant and developing rat testicular gonadotropin and prolactin receptors and steroidogenesis by treatments with human chorionic gonadotropin, gonadotropin-releasing hormone analogs, bromocriptine, prolactin, and estrogen. Biol Reprod 32: 721 732.
9. Kim HH, Mui KL, Nikrodhanond AA, Tamayo NC (2007) Regulation of gonadotropin-releasing hormone in nonhypothalamic tissues. Semin Reprod Med 25: 326 336.
10. Kogo H, Fujimoto T, Mori T (1999) Evidence for gonadotropin-releasing hormone receptor mRNA expression by estrogen in rat granulosa cells. Cell Tissue Res 297: 459 465.
11. Kraus S, Naor Z, Seger R (2006) Gonadotropin-releasing hormone in apoptosis of prostate cancer cells. Cancer Lett 234: 109 123.
12. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez J, Candas B (2005) Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocr Rev 26: 361 379.
13. Marelli MM, Moretti RM, Januszkiewicz-Caulier J, Motta M, Limonta P (2006) Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients? Curr Cancer Drug Targets 6: 257 269.
14. Rothman MS, Wierman ME (2007) The role of gonadotropin releasing hormone in normal and pathologic endocrine processes. Curr Opin Endocrinol Diabetes Obes 14: 306 310.
15. Sridaran R, Hisheh S, Dharmarajan AM (1998) Induction of apoptosis by a gonadotropin-releasing hormone agonist during early pregnancy in the rat. Apoptosis 3: 51 57.
16. St-Arnaud R, Lachance R, Kelly SJ, Belanger A, Dupont A, Labrie F (1986) Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen. Clin Endocrinol (Oxf) 24: 21 30.
17. Sweetman SC (2007) Martindale: The Complete Drug Reference. Pharmaceutical Press
18. Tapanainen J, Hovatta O, Juntunen K, Martikainen H, Ratsula K, Tulppala M, Tuomivaara L (1993a) Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study. Hum Reprod 8: 2052 2055.
19. Tapanainen JS, Tilly JL, Vihko KK, Hsueh AJ (1993b) Hormonal control of apoptotic cell death in the testis: gonadotropins and androgens as testicular cell survival factors. Mol Endocrinol 7: 643 650.
20. Woolveridge I, Bryden AA, Taylor MF, George NJ, Wu FC, Morris ID (1998) Apoptosis and expression of apoptotic regulators in the human testis following short-and long-term anti-androgen treatment. Mol Hum Reprod 4: 701 707.